India's Jubilant Pharmova sees worst day in near a month on USFDA observations
** Shares of Indian pharma and life sciences company
Jubilant Pharmova Ltd JUBA.NS fall as much as 3.1% to 388.30
rupees, marking sharpest intraday pct loss since Nov. 17
** Stock hits lowest level since Dec. 9, on track for a
third consecutive session of losses
** JUBA on Wednesday said USFDA issued 8 observations after
an inspection of their Nanjangud facility
** More than 553,000 shares change hands by 3:00 p.m. IST
IST, 2.2x the 30-day avg of 257,478 shares
(Reporting by Anisha Ajith in Bengaluru)
((anisha.ajith@thomsonreuters.com))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures